SCHEMBL6266552

SCHEMBL6266552

CCC(=O)N(c1ccccc1)N1CCCCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.49
OPRM1 P35372 10/20 0.45
OPRD1 P41143 3/20 0.45
SLC22A1 O15245 1/20 0.42
NR1I2 O75469 1/20 0.42
ABCB1 P08183 1/20 0.42
CHRM1 P11229 1/20 0.42
DRD2 P14416 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
CHRM3 P20309 1/20 0.42
MAOA P21397 1/20 0.42
DRD4 P21917 1/20 0.42
MAOB P27338 1/20 0.42
ADRA1A P35348 1/20 0.42
HRH1 P35367 1/20 0.42
ADRA1B P35368 1/20 0.42
DRD3 P35462 1/20 0.42
OPRK1 P41145 1/20 0.42
CHRNA4 P43681 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2639776 0.83 ALDH1A1 (0.46) SIGMAR1OPRM1OPRD1SLC22A1CHRM1
SCHEMBL18428973 0.81 ALDH1A1 (0.45) SIGMAR1CHRM1CHRM3ALDH1A1POLB
SCHEMBL4142245 0.81 ALDH1A1 (0.47) ALDH1A1POLBSMN1; SMN2
SCHEMBL1325734 0.80 OPRM1 (0.43) SIGMAR1OPRM1OPRD1ALDH1A1POLB
SCHEMBL8544469 0.79 ALDH1A1 (0.45) ALDH1A1POLBSMN1; SMN2
SCHEMBL11239286 0.79 OPRM1 (0.40) SIGMAR1OPRM1OPRD1SLC22A1NR1I2
SCHEMBL3964785 0.78 ALDH1A1 (0.45) ALDH1A1POLBSMN1; SMN2
SCHEMBL28026626 0.76 ALDH1A1 (0.42) ALDH1A1POLBSMN1; SMN2
SCHEMBL28275930 0.76 OPRM1 (0.38) SIGMAR1OPRM1OPRD1SLC22A1NR1I2
SCHEMBL12473807 0.73 ALDH1A1 (0.41) ALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190117637-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-04-25 US disclosed
EP-1411942-A4 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMA CORP (US) 2005-01-26 EP disclosed
EP-1411942-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS Synaptic Pharmaceutical Corporation (US) 2004-04-28 EP disclosed
WO-2003004027-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2003-01-16 WO disclosed
US-5214148-A Analgesic N-phenyl-N-(3-OR1 -3-ME-4-piperidinyl)amides GLAXO INC. (US) 1993-05-25 US disclosed
EP-0396282-A2 N-aryl-N-[4-(heterocyclicalkyl) piperidinyl]amides and pharmaceutical compositions and methods employing such compounds BOC, INC. (US) 1990-11-07 EP disclosed